Projects Showing 1 - 18 out of 51 results Filter by Program - Any -Aboriginal and Torres Strait Islander Health ProgramAsia and Pacific Health ProgramBiosecurity ProgramBiostatistics and Databases ProgramGlobal Health ProgramHIV Epidemiology and Prevention ProgramImmunovirology and Pathogenesis ProgramInfection Analytics ProgramSexual Health ProgramSurveillance and Evaluation Research ProgramTherapeutic and Vaccine Research ProgramViral Hepatitis Clinical Research ProgramViral Hepatitis Epidemiology and Prevention ProgramViral Immunology Systems Program Keywords Focus areas - Any -Aboriginal and Torres Strait Islander healthCOVID-19 and emerging infectionsGlobal healthHIVHPVSexual healthViral hepatitis Research strengths - Any -Biostatistics, modelling and analysisCapacity buildingClinical trials and cohortsEpidemiology and surveillanceHealth economics and health systemsImmunovirologyNew diagnostic approachesPublic health interventionsSocial and behavioural sciences Status - Any -CurrentCompleted View more Sort by Earliest firstLatest firstTitle A - ZTitle Z - A OPTIMAR Optimising metabolic management on integrase based ART STRIDE: Stronger Investments for Infectious Diseases PANTHER Study: Treating anal neoplasia in people living with HIV BRIDGE (Bringing RNA Innovations through the Developmental Gap Effectively) Invitation for Expression of Interest The BRIDGE consortium is extending an invitation for expressions of interest (EOI) pertaining to RNA-based candidates with the potential to significantly contribute to the prevention of SARS-CoV-2 ... The CIRCUIT Study Comparing Immunisation-Boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies Study Accurately defining the distribution of HIV-1 reservoir during the first 3 years of integrase inhibitor containing antiretroviral therapy The ETHOS ENGAGE Study Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings REal World Assessment of people living with Chronic Hepatitis B in Australia (REACH-B) Treatment of HOsPitalised Inpatients for hepatitis C (TOPIC) The DOMINO Study Measuring and mitigating the indirect effects of COVID-19 on tuberculosis and HIV care in Indonesia The TEMPO Study The National Australian HCV Point-of-Care Testing Program Preparing for Injectable PrEP The REACT Study A randomised study of interferonâfree treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection HBV POCT Evaluation of a novel hepatitis B DNA test from capillary blood at the point-of-care as a tool to enhance clinical management Determining the impacts of COVID-19 restrictions on people who use drugs (CODE) RELEASE How does long-acting depot buprenorphine impact on the high-risk post-release period for people with opioid dependence? STRIVE Strategies and Treatments for Respiratory Infections and Viral Emergencies Pagination Current page 1 Page 2 Page 3 Next page > Last page >>
BRIDGE (Bringing RNA Innovations through the Developmental Gap Effectively) Invitation for Expression of Interest The BRIDGE consortium is extending an invitation for expressions of interest (EOI) pertaining to RNA-based candidates with the potential to significantly contribute to the prevention of SARS-CoV-2 ...
The CIRCUIT Study Comparing Immunisation-Boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies Study
Accurately defining the distribution of HIV-1 reservoir during the first 3 years of integrase inhibitor containing antiretroviral therapy
The ETHOS ENGAGE Study Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings
The DOMINO Study Measuring and mitigating the indirect effects of COVID-19 on tuberculosis and HIV care in Indonesia
The REACT Study A randomised study of interferonâfree treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection
HBV POCT Evaluation of a novel hepatitis B DNA test from capillary blood at the point-of-care as a tool to enhance clinical management
RELEASE How does long-acting depot buprenorphine impact on the high-risk post-release period for people with opioid dependence?
